7-Fluorotryptamine
| Clinical data | |
|---|---|
| Other names | 7-F-T; 7-Fluoro-T; 7-FT |
| Drug class | Serotonin receptor modulator; GPRC5Aagonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID |
|
| ChemSpider |
|
| ChEMBL |
|
| CompTox Dashboard(EPA) |
|
| ECHA InfoCard | 100.197.219 |
| Chemical and physical data | |
| Formula | CHFN |
| Molar mass | 178.210 g·mol−1 |
| 3D model (JSmol) |
|
| |
| |
7-Fluorotryptamine (7-FT) is a serotonin receptor modulator and weak GPRC5Aagonist of the tryptamine family.[1][2] It is the 7-fluoroderivative of tryptamine.[2] The drug is a low-potency agonist of the orphan receptor GPRC5A, with an ECTooltip half-maximal effective concentration of 7,200 nM.[1][2][3] In addition to its GPRC5A agonism, 7-fluorotryptamine interacts with other receptors, such as the serotonin5-HT receptor.[2] Derivatives of 7-fluorotryptamine have been described.[4] 7-Fluorotryptamine was first described in the scientific literature by 1979.[5] Its GPRC5A agonism was first described in 2023.[2]
See also
ลิงก์ภายนอก
- 7-ฟลูออโรทริปตามีน - การออกแบบไอโซเมอร์